Essential fatty acid deficiency in well nourished young cystic fibrosis patients

European Journal of Pediatrics

Volumn 156, Issue 12, 1997, Pages 952-956

  Roulet, M ^a   Frascarolo, P ^a   Rappaz, I ^a   Pilet, M ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Body composition; Cystic Fibrosis; Essential fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; ICOSATRIENOIC ACID; LINOLEIC ACID; PALMITOLEIC ACID; PHOSPHOLIPID;

ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ESSENTIAL FATTY ACID DEFICIENCY; FATTY ACID METABOLISM; FEMALE; HUMAN; MALABSORPTION; MALE; NUTRITIONAL STATUS; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION;

ADOLESCENT; ADULT; BODY COMPOSITION; CHILD; CYSTIC FIBROSIS; FATTY ACIDS, ESSENTIAL; FEMALE; HUMANS; MALE; NUTRITIONAL STATUS; PHOSPHOLIPIDS;

EID: 0031453452     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050750     Document Type: Article

References (41)

1. Buchdahl RM, Fulleylove C, Marchant JL, Warner JO, Brueton MJ (1989) Energy and nutrient intakes in cystic fibrosis. Arch Dis Child 64:373-378
2. Chan GM (1992) Performance of dual-energy X-ray absorptiometry in evaluating bone, lean body mass, and fat in pediatric subjects. J Bone Miner Res 7:369-374
3. Chrispin AR, Norman AP (1974) The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol 2:101-106
4. Christie WW (1989) Gas chromatography and lipids: a practical guide. The Oily Press Ltd.
5. Colarow L (1989) Quantitation of phospholipid classes on thin layer plates with a fluorescence reagent in the mobile phase. J Planar Chromatogr 2:19-23
6. Colarow L (1990) Quantitative transmittance densitometry of phospholipids after their specific detection with a molybdate reagent on silica gel plates. J Planar Chromatogr 3:228-231
7. Corey M, Farewell V (1996) Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 143:1007-1017
8. Deurenberg P, Pieters JJL, Hautvast JGAJ (1990) The assessment of the body fat percentage by skin fold thickness measurements in childhood and young adolescence. Br J Nutr 63:293-303
9. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, Meer JWM van der, Cannon JG, Rogers TS, Klempner MS, Weber PC, Schaefer EJ, Wolff SM, Dinarello CA (1989) The effect of dietary supplementation with n-3 polyunsatured fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320:265-271
10. Farrell PM, Mischler EH, Engle MJ, Brown DJ, Lau SM (1985) Fatty acid abnormalities in cystic fibrosis. Pediatr Res 19:104-109
11. Folch J, Lees M, Stanley GHS (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509
12. Gaskin KJ, Waters DLM, Soutier VL, Baur L, Allen BJ, Blagojevic N, Parson D (1990) Body composition in cystic fibrosis. Basic Life Sci 55:15-21
13. Gorlin R (1988) The biological actions and potential clinical significance of dietary Omega 3 fatty acids. Arch Intern Med 148:2043-2048
14. Holman RT (1960) The ratio of trienoic:tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement. J Nutr 70:405-410
15. Hubbard VS, Dunn GD, Saint Agnese PA di (1977) Abnormal fatty acid composition of plasma-lipids in cystic fibrosis: a primary and secondary defect? Lancet II:1302-1304
16. Kang JX, Man SFP, Brown NE, Labrecque PA, Clandinin MT (1992) The chloride channel blocker anthracene-carboxylate inhibits fatty acid incorporation into phospholipid in cultured human airway epithelial cells. Biochem J 285:725-729
17. Keicher U, Koletzko B, Reinhardt D (1995) Omega-3 fatty acids suppress the enhanced production of 5-lipo-oxygenase products from polymorph neutrophil granulocytes in cystic fibrosis. Eur J Clin Invest 25:915-919
18. Kraemer R, Rüdeberg A, Hadorn B, Rossi E (1978) Relative underweight in cystic fibrosis and its prognostic value. Acta Paediatr Scand 67:33-37
19. Kuo PT, Huang NN, Bassett DR (1962) The fatty acid composition of the serum chylomicrons and adipose tissue of children with cystic fibrosis of the pancreas. J Pediatr 60:394-403
20. Landon C, Kerner JA, Castillo R, Adams L, Whalen R, Lewiston NJ (1981) Oral correction of essential fatty acid deficiency in cystic fibrosis. JPEN 5:501-504
21. Lee TH, Hoover RL, Williams JD (1985) Effects of dietary enrichment with eicosapentanoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 312:1217-1224
22. Lepage G, Roy CC (1986) Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27:114-120
23. Lepage G, Levy E, Ronco N, Smith L, Galeano N, Roy CC (1989) Direct transesterification of plasma fatty acids for the diagnosis of essential fatty acids deficiency in cystic fibrosis. J Lipid Res 30:1483-1490
24. Llooyd-Still JD, Johnson SB, Holman RT (1981) Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation. Am J Clin Nutr 34:1-7
25. Manner T, Katz DP, Skeie B, Newsholme E, Kirvela O, Askanazi J (1993) Fish oils and the lung (review) Clin Nutr 12:131-146
26. Meydani SN, Dinarello CA (1993) Influence of dietary fatty acids on cytokine production and its clinical implications. Nutr Clin Pract 8:65-72
27. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB (1986) Arachidonic acid metabolism. Ann Rev Biochem 55:69-102
28. Parson HG, O'Loughlin EV, Forbes D, Cooper D, Gall DG (1988) Supplemental calories improve essential fatty acid deficiency in cystic fibrosis patients. Pediatr Res 24:353-356
29. Portal BC, Richard MJ, Faure HS, Hadjian AJ, Favier AE (1995) Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 61:843-847
30. Prescott SM (1984) The effect of eicosapentaenoic acid on the leukotriene production by human neutrophils. J Biol Chem 259:615-621
31. Rochat T, Slosman DO, Pichard C, Belli DC (1994) Body composition analysis by dual-energy X-ray absorptiometry in adults with cystic fibrosis. Chest 106:800-805
32. Rogiers V, Dab I, Crokaert R, Vis HL (1980) Long chain non-esterified fatty acid pattern in plasma of cystic fibrosis patients and their parents. Pediatr Res 14:1088-1091
33. Rogiers V, Dab I, Michotte Y (1984) Abnormal fatty acid turnover in the phospholipids of the red blood cell membranes of the cystic fibrosis patients. Pediatr Res 18:704-708
34. Rosenlund ML, Kim HK, Kritchevsky D (1974) Essential fatty acids in cystic fibrosis (letter). Nature 251:719
35. Roulet M (1994) Protein-energy malnutrition in cystic fibrosis patients. Acta Paediatr Scand [Suppl] 395:43-48
36. Shwachman H, Kulczycki LL (1958) Long-term study of one hundred five patients with cystic fibrosis. Am J Dis Child 96:6-15
37. Sperling RI, Benincaso AI, Knoel CT, Larkin JK, Austen KF, Robinson DR (1993) Dietary omega-3 polyunsatured fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 91:651-660
38. Strandvik B (1989) Relation between essential fatty acid metabolism and gastrointestinal symptoms in cystic fibrosis. Acta Paediatr Scand [Suppl] 363:58-65
39. Strandvik B, Brönnegard M, Gilljam H, Carlstedt-Duke J (1988) Relation between defective regulation of arachidonic acid release and symptoms in cystic fibrosis. Scand J Gastroenterol 23[Suppl] 143:1-4
40. Winklhofer-Roob BM, Ziouzenkova O, Puhl H, Ellemunter H, Greiner P, Muller G, van't Hof MA, Esterbauer H, Shmerling DH (1995) Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: improvement during vitamin E supplementation. Free Radical Biology and Medicine 19:725-733
41. Yetiv JZ (1988) Clinical applications of fish oils. JAMA 260:665-670